( , , )

: Rotateq (rotavirus Vaccine, Live, Oral, Pentavalent). ?  »
|
-

PER OS

Suspension

RotaTeq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by the serotypes G1, G2, G3, and G4 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. The first dose of RoraTeq should be administered betwen 6 and 12 weeks of age.

136 76 31569 00

Merck Sharp & Dohme Corp., Usa

05/2012 - 05/2022

.
, .
.
/
Rotavirus g1 reassortant 2.2 X10 ^6 IU/DOSE
Rotavirus g2 reassortant 2.8 X10 ^6 IU/DOSE
Rotavirus g3 reassortant 2.2 X10 ^6 IU/DOSE
Rotavirus g4 reassortant 2.0 X10^ 6 IU/DOSE
Rotavirus p1 reassortant 2.3 X10 ^6 IU/DOSE
Container unit dose plastic 10 x 24
Container unit dose plastic 1 x 24

*

*

 

.

?

!
!
 »
 
" !
 

? !
 »
169
-